Bamco Inc Bio Techne Corp Transaction History

Bamco Inc

$36.8 Billion
Q3 2024

A detailed history of Bamco Inc transactions in Bio Techne Corp stock. As of the latest transaction made, Bamco Inc holds 4,445,540 shares of TECH stock, worth $300 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares

4,445,540

Previous 4,776,592 6.93%

Holding current value

$300 Million

Previous $342 Million 3.8%

% of portfolio

0.97%

Previous 1.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$70.96 - $82.35 $23.5 Million - $27.3 Million	-331,052 Reduced 6.93%	4,445,540 $355 Million
Q2 2024 Aug 14, 2024	SELL	$62.12 - $84.15 $13.8 Million - $18.6 Million	-221,618 Reduced 4.43%	4,776,592 $342 Million
Q1 2024 May 15, 2024	SELL	$65.98 - $77.09 $23.3 Million - $27.3 Million	-353,796 Reduced 6.61%	4,998,210 $352 Million
Q4 2023 Feb 14, 2024	SELL	$52.83 - $78.22 $1.27 Million - $1.87 Million	-23,953 Reduced 0.45%	5,352,006 $413 Million
Q3 2023 Nov 14, 2023	SELL	$67.52 - $89.42 $304,852 - $403,731	-4,515 Reduced 0.08%	5,375,959 $366 Million
Q2 2023 Aug 14, 2023	BUY	$73.76 - $85.98 $72,432 - $84,432	982 Added 0.02%	5,380,474 $439 Million
Q1 2023 May 15, 2023	SELL	$71.62 - $86.62 $10 Million - $12.1 Million	-139,570 Reduced 2.53%	5,379,492 $399 Million
Q4 2022 Feb 14, 2023	BUY	$80.67 - $352.29 $330 Million - $1.44 Billion	4,091,998 Added 286.74%	5,519,062 $457 Million
Q3 2022 Nov 14, 2022	SELL	$282.54 - $391.85 $6.87 Million - $9.53 Million	-24,312 Reduced 1.68%	1,427,064 $405 Million
Q2 2022 Aug 15, 2022	SELL	$322.67 - $449.65 $5.72 Million - $7.98 Million	-17,742 Reduced 1.21%	1,451,376 $503 Million
Q1 2022 May 13, 2022	SELL	$353.85 - $487.79 $4.9 Million - $6.75 Million	-13,835 Reduced 0.93%	1,469,118 $636 Million
Q4 2021 Feb 14, 2022	SELL	$456.15 - $525.06 $4.98 Million - $5.74 Million	-10,925 Reduced 0.73%	1,482,953 $767 Million
Q3 2021 Nov 12, 2021	SELL	$444.87 - $538.88 $1.83 Million - $2.22 Million	-4,123 Reduced 0.28%	1,493,878 $724 Million
Q2 2021 Aug 13, 2021	BUY	$387.35 - $450.26 $1.05 Million - $1.22 Million	2,705 Added 0.18%	1,498,001 $674 Million
Q1 2021 May 19, 2021	BUY	$314.62 - $411.0 $561,911 - $734,046	1,786 Added 0.12%	1,495,296 $571 Million
Q4 2020 Feb 12, 2021	SELL	$246.9 - $321.87 $433,803 - $565,525	-1,757 Reduced 0.12%	1,493,510 $474 Million
Q3 2020 Nov 13, 2020	SELL	$232.22 - $282.96 $5.39 Million - $6.57 Million	-23,216 Reduced 1.53%	1,495,267 $370 Million
Q2 2020 Aug 14, 2020	SELL	$185.43 - $279.56 $1.46 Million - $2.21 Million	-7,893 Reduced 0.52%	1,518,483 $401 Million
Q1 2020 May 15, 2020	SELL	$161.17 - $221.51 $1.16 Million - $1.59 Million	-7,198 Reduced 0.47%	1,526,376 $289 Million
Q4 2019 Feb 18, 2020	SELL	$189.68 - $222.09 $7.77 Million - $9.1 Million	-40,972 Reduced 2.6%	1,533,574 $337 Million
Q3 2019 Nov 14, 2019	BUY	$183.56 - $216.72 $1.14 Million - $1.35 Million	6,226 Added 0.4%	1,574,546 $308 Million
Q2 2019 Aug 15, 2019	BUY	$188.72 - $215.43 $12,455 - $14,218	66 Added 0.0%	1,568,320 $327 Million
Q1 2019 May 15, 2019	BUY	$136.09 - $200.44 $4.69 Million - $6.91 Million	34,456 Added 2.25%	1,568,254 $311 Million
Q4 2018 Feb 14, 2019	BUY	$132.75 - $203.8 $3.26 Million - $5.01 Million	24,574 Added 1.63%	1,533,798 $222 Million
Q3 2018 Nov 14, 2018	SELL	$147.44 - $204.11 $178,402 - $246,973	-1,210 Reduced 0.08%	1,509,224 $308 Million
Q2 2018 Aug 14, 2018	SELL	$144.9 - $165.58 $1.43 Million - $1.64 Million	-9,889 Reduced 0.65%	1,510,434 $223 Million
Q1 2018 May 09, 2018	BUY	$131.46 - $151.04 $440,128 - $505,681	3,348 Added 0.22%	1,520,323 $230 Million
Q4 2017 Feb 14, 2018	SELL	$121.17 - $134.75 $394,166 - $438,341	-3,253 Reduced 0.21%	1,516,975 $197 Million
Q3 2017 Nov 15, 2017	BUY	$113.59 - $123.78 $173 Million - $188 Million	1,520,228	1,520,228 $184 Million

Others Institutions Holding TECH

# of Institutions

603

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.65B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

News

Stay updated on Bamco Inc with notifications on news.

Account